[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE417512B - Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav - Google Patents

Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav

Info

Publication number
SE417512B
SE417512B SE7404352A SE7404352A SE417512B SE 417512 B SE417512 B SE 417512B SE 7404352 A SE7404352 A SE 7404352A SE 7404352 A SE7404352 A SE 7404352A SE 417512 B SE417512 B SE 417512B
Authority
SE
Sweden
Prior art keywords
furanar
estars
salts
substituted
procedure
Prior art date
Application number
SE7404352A
Other languages
English (en)
Inventor
R A Parker
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of SE417512B publication Critical patent/SE417512B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7404352A 1973-04-02 1974-04-01 Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav SE417512B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/347,064 US4110351A (en) 1973-04-02 1973-04-02 Hypolipidemic agents RO- or RS- substituted furoic acids, esters and salts

Publications (1)

Publication Number Publication Date
SE417512B true SE417512B (sv) 1981-03-23

Family

ID=23362171

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7404352A SE417512B (sv) 1973-04-02 1974-04-01 Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav

Country Status (13)

Country Link
US (2) US4110351A (sv)
JP (1) JPS5844668B2 (sv)
AU (1) AU473143B2 (sv)
BE (1) BE813040A (sv)
CA (1) CA1077051A (sv)
CH (1) CH593960A5 (sv)
DE (1) DE2414680C2 (sv)
FR (1) FR2223030B1 (sv)
GB (1) GB1413648A (sv)
NL (1) NL178967C (sv)
PH (1) PH17946A (sv)
SE (1) SE417512B (sv)
ZA (1) ZA741420B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017514A (en) * 1975-06-16 1977-04-12 Richardson-Merrell Inc. Hypolipidemic agents
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
JPS621279U (sv) * 1985-06-17 1987-01-07
US4980371A (en) * 1988-12-21 1990-12-25 Merrell Dow Pharmaceuticals Antiretroviral furan ketones
US5759837A (en) * 1989-01-17 1998-06-02 John Hopkins University Chemotherapy for cancer by inhibiting the fatty acid biosynthetic pathway
US5665874A (en) * 1989-01-17 1997-09-09 John Hopkins University Cancer related antigen
US5759791A (en) * 1989-01-17 1998-06-02 The Johns Hopkins University Cancer related antigen
US5614551A (en) * 1994-01-24 1997-03-25 The Johns Hopkins University Inhibitors of fatty acid synthesis as antimicrobial agents
US5981575A (en) * 1996-11-15 1999-11-09 Johns Hopkins University, The Inhibition of fatty acid synthase as a means to reduce adipocyte mass
US7576131B2 (en) * 1999-06-04 2009-08-18 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6624194B1 (en) * 1999-06-04 2003-09-23 Metabolex, Inc. Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
US6262118B1 (en) 1999-06-04 2001-07-17 Metabolex, Inc. Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia
US7199259B2 (en) * 2003-06-20 2007-04-03 Metabolex, Inc. Resolution of α-(phenoxy)phenylacetic acid derivatives
WO2005115384A2 (en) * 2004-05-25 2005-12-08 Metabolex, Inc. Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
CN1997633A (zh) * 2004-05-25 2007-07-11 麦它波莱克斯股份有限公司 作为ppar调节剂的取代的三唑及其制备方法
US7714131B2 (en) * 2005-09-23 2010-05-11 Metabolex, Inc. Process for the stereoselective preparation of (−)-halofenate and derivatives thereof
CA2668414C (en) * 2006-11-03 2015-02-10 Qlt Inc. Methods of treating dermatological disorders or conditions
AU2013203113B2 (en) * 2009-07-08 2015-03-26 Dermira (Canada), Inc. TOFA analogs useful in treating dermatological disorders or conditions
BR112012000254A2 (pt) 2009-07-08 2016-02-16 Dermira Canada Inc análogos de tofa úteis no tratamento de distúrbios ou condições dermatológicas.
DK3253743T3 (da) 2015-02-05 2019-08-19 Dermira Inc Syntetisk fremgangsmåde til fremstilling af 2-furansyre-derivater
WO2019072478A1 (en) 2017-10-10 2019-04-18 Galderma Research & Development SPECIFIC ACETYL-COA CARBOXYLASE INHIBITORS FOR USE IN THE TREATMENT AND / OR PREVENTION OF ACNE
WO2024026012A1 (en) * 2022-07-29 2024-02-01 The Regents Of The University Of California Compositions and methods for treating metabolic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3517050A (en) * 1966-10-03 1970-06-23 Merck & Co Inc Ester and amide derivative of (3-trifluoromethylphenoxy) (4 - halophenyl)acetic acid
US3716644A (en) * 1971-07-15 1973-02-13 American Cyanamid Co Hypolipidemic agents

Also Published As

Publication number Publication date
DE2414680C2 (de) 1983-12-22
CH593960A5 (sv) 1977-12-30
NL178967B (nl) 1986-01-16
CA1077051A (en) 1980-05-06
BE813040A (fr) 1974-07-15
GB1413648A (en) 1975-11-12
NL178967C (nl) 1986-06-16
JPS49127963A (sv) 1974-12-07
ZA741420B (en) 1975-01-29
US4146623A (en) 1979-03-27
AU473143B2 (en) 1976-06-17
DE2414680A1 (de) 1974-10-17
JPS5844668B2 (ja) 1983-10-04
AU6640974A (en) 1975-09-11
US4110351A (en) 1978-08-29
PH17946A (en) 1985-02-11
FR2223030A1 (sv) 1974-10-25
NL7404425A (sv) 1974-10-04
FR2223030B1 (sv) 1977-05-06

Similar Documents

Publication Publication Date Title
SE417512B (sv) Forfarande for framstellning av substituerade furankarboxylsyror samt estrar och salter derav
NO142258C (no) Fremgangsmaate for fremstilling av alfa-aryl-propionsyrer
SE423385B (sv) Forfarande for framstellning av cykloalitatiska aminosyror och estrar derav
NO803337L (no) Analogifremgangsmaate for fremstilling av nye terapeutisk virksomme benzimidazolylacetohydroksamsyrer
SE414181B (sv) Forfarande for framstellning av polylaktoner bestaende av inter- och intramolekylera estrar av poly-alfa-hydroxiakrylsyror
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
NO791012L (no) Kontinuerlig fremgangsmaate for fremstilling av karboksylpersyrer
SE409855B (sv) Forfarande for framstellning av hydroxisubstituerade bifenylylpropionsyror och derivat derav
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE406195B (sv) Forfarande for framstellning av bensocykloheptaisokinolinderivat samt syraadditionssalter derav
BE781997A (fr) Procede de preparation d'acides et d'anhydrices carboxyliques
SE420622B (sv) Forfarande for framstellning av 6-aminopenicillansyra och enzymkomlex herfor
SE7601151L (sv) Forfarande for framstellning av cefemkarboxylsyror
NO144525C (no) Fremgangsmaate til fremstilling av salter av klorerte eddiksyrer
SE422796B (sv) Forfarande for framstellning av 6,11-dihydro-11-oxo-dibens (b,e)-oxepin-alkankarboxylsyror
SE7604669L (sv) Forfarande for framstellning av estrar av tiokarbamidsyror
SE388195B (sv) Forfarande for framstellning av 2,5-dihydroxibensensulfonsyraderivat med hemostatisk hypokolesterolemisk, hypotriglyceridemisk och hypolipemisk verkan
SE398882B (sv) Forfarande for framstellning av salter av aminosyror och polysvavelsyraestrar av naturliga glykopeptider
NO140135C (no) Fremgangsmaate for fremstilling av d(-)-penicillamin og salter av dette
AR198489A1 (es) Procedimiento para la preparacion de nuevos derivados de acidos piridin-aceticos
SE7604940L (sv) Forfarande for framstellning av sulfamylbensoesyror
SE418395B (sv) Forfarande for framstellning av indanettiksyror
IT1044242B (it) Procedimento per la preparazione di acidi 2 alcossi 5 alchil sulfonilbenzoici
SE398352B (sv) Forfarande for framstellning av x-aminocyklopropylacetamidopenicillansyror och x-aminocyklobutylacetaamidopenicillansyror
SE417828B (sv) Forfarande for framstellning av halogenpropylsubstituerade fenoxialkansyror och legre alkylestrar derav

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7404352-2

Effective date: 19940510

Format of ref document f/p: F